PreDxion Bio Company
PreDxion Bio aims to revolutionize critical care medicine by providing ICU doctors with actionable patient immune function data
Industry:
P4 Medicine
Technology:
Other
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Investors Number:
3
Headquarters:
Others
Employee Number:
1-10
Investor Type:
For Profit
Total Funding:
$120K
Founded Date:
2016-02-02
Last Funding Type:
Seed